AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimat M 30mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Matilda Pharmaceuticals (india) Private Limited

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Glimat M 30mg/500mg Tablet SR

Diabetic patients (adults) with type 2 diabetes mellitus may benefit from Glymida, a dual-action anti-diabetic medication combining two active agents (30mg/500mg sustained-release tablets). This formulation helps regulate blood glucose. Glymida should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is vital; discontinuation without medical guidance can lead to elevated blood sugar, increasing the risk of complications such as kidney impairment, vision loss, neuropathy, and limb loss. Glymida is one component of a comprehensive diabetes management plan that includes diet, exercise, and weight management as directed by your doctor. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are crucial to manage hypoglycemia. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalgia, and upper respiratory infections. Weight gain is also a possibility. Glymida is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiac disease should inform their physician before initiating Glymida treatment. Pregnant or lactating women should seek medical counsel prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are necessary during Glymida therapy.

Uses of Glimat M 30mg/500mg Tablet SR

Adult-onset diabetes

Major Benefits of Glimat M 30mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Glimat M 30mg/500mg Sustained-Release tablets should be taken with a meal.

Common Side effects of Glimat M 30mg/500mg Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glimat M 30mg/500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimat M 30mg/500mg Sustained-Release Tablets should be administered with a meal.

How Glimat M 30mg/500mg Tablet SR works:

Glimat M SR tablets (30mg/500mg) contain gliclazide and metformin, working together to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimat M 30mg/500mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Glimat M 30mg/500mg tablets pose a confirmed risk to a developing fetus and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Glimat M 30mg/500mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimat M 30mg/500mg SR tablets to individuals with impaired kidney function; dosage modification may be necessary. Consult a physician for guidance. Glimat M 30mg/500mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimat M 30mg/500mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician. A low initial dose is typically recommended for those with mild to moderate hepatic dysfunction; however, its use is contraindicated in individuals with severe liver disease.

What if you forget to take Glimat M 30mg/500mg Tablet SR :

Should you forget to take a Glimat M 30mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Glimat M 30mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimat M 30mg/500mg Tablet SR

Glimat M 30mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Glimat M 30mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glimat M 30mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glimat M 30mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is less likely to occur if you have healthy kidneys, are not elderly, and avoid excessive alcohol consumption. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glimat M and seek immediate medical attention.
Prolonged use of Glimat M 30mg/500mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glimat M 30mg/500mg Tablet SR is contraindicated in patients with known allergies to its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis (including diabetic ketoacidosis).
Combining Glimat M 30mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimat M 30mg/500mg SR tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide boosts insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimat M 30mg/500mg SR tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glimat M 30mg/500mg SR Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glimat M 30mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glimat M and seek immediate medical attention.
Prolonged use of Glimat M 30mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplementation with external vitamin B12 sources is recommended by some researchers.
Glimat M 30mg/500mg SR Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glimat M 30mg/500mg SR tablets with alcohol is unsafe. This combination can dangerously lower blood sugar and raise the risk of lactic acidosis.
Glimat M 30mg/500mg Table...
57
MRP 70
18% off